These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 21078907)

  • 1. Downstream of tyrosine kinase 1 and 2 play opposing roles in CD200 receptor signaling.
    Mihrshahi R; Brown MH
    J Immunol; 2010 Dec; 185(12):7216-22. PubMed ID: 21078907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Essential roles for Dok2 and RasGAP in CD200 receptor-mediated regulation of human myeloid cells.
    Mihrshahi R; Barclay AN; Brown MH
    J Immunol; 2009 Oct; 183(8):4879-86. PubMed ID: 19786546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms of CD200 inhibition of mast cell activation.
    Zhang S; Cherwinski H; Sedgwick JD; Phillips JH
    J Immunol; 2004 Dec; 173(11):6786-93. PubMed ID: 15557172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential role of Dok1 and Dok2 in TLR2-induced inflammatory signaling in glia.
    Downer EJ; Johnston DG; Lynch MA
    Mol Cell Neurosci; 2013 Sep; 56():148-58. PubMed ID: 23659921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of tyrosine residues crucial for CD200R-mediated inhibition of mast cell activation.
    Zhang S; Phillips JH
    J Leukoc Biol; 2006 Feb; 79(2):363-8. PubMed ID: 16330532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. All-trans retinoic acid induces p62DOK1 and p56DOK2 expression which enhances induced differentiation and G0 arrest of HL-60 leukemia cells.
    Lamkin TJ; Chin V; Yen A
    Am J Hematol; 2006 Aug; 81(8):603-15. PubMed ID: 16823827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential regulation of adapter proteins Dok2 and Dok1 in platelets, leading to an association of Dok2 with integrin alphaIIbbeta3.
    Hughan SC; Watson SP
    J Thromb Haemost; 2007 Feb; 5(2):387-94. PubMed ID: 17092301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dok1 and Dok2 Proteins Regulate Cell Cycle in Hematopoietic Stem and Progenitor Cells.
    Coppin E; De Grandis M; Pandolfi PP; Arcangeli ML; Aurrand-Lions M; Nunès JA
    J Immunol; 2016 May; 196(10):4110-21. PubMed ID: 27183638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DOK1 and DOK2 regulate CD8 T cell signaling and memory formation without affecting tumor cell killing.
    Laletin V; Bernard PL; Montersino C; Yamanashi Y; Olive D; Castellano R; Guittard G; Nunès JA
    Sci Rep; 2024 Jul; 14(1):15053. PubMed ID: 38956389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dok2 mediates the CD200Fc attenuation of Aβ-induced changes in glia.
    Lyons A; Downer EJ; Costello DA; Murphy N; Lynch MA
    J Neuroinflammation; 2012 May; 9():107. PubMed ID: 22642833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Dok1 in cell signaling mediated by RET tyrosine kinase.
    Murakami H; Yamamura Y; Shimono Y; Kawai K; Kurokawa K; Takahashi M
    J Biol Chem; 2002 Sep; 277(36):32781-90. PubMed ID: 12087092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stromal cell-derived factor-1alpha/CXCL12-induced chemotaxis of T cells involves activation of the RasGAP-associated docking protein p62Dok-1.
    Okabe S; Fukuda S; Kim YJ; Niki M; Pelus LM; Ohyashiki K; Pandolfi PP; Broxmeyer HE
    Blood; 2005 Jan; 105(2):474-80. PubMed ID: 15345598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissection of agonistic and blocking effects of CD200 receptor antibodies.
    Akkaya M; Aknin ML; Akkaya B; Barclay AN
    PLoS One; 2013; 8(5):e63325. PubMed ID: 23691022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dok1 and Dok2 proteins regulate natural killer cell development and function.
    Celis-Gutierrez J; Boyron M; Walzer T; Pandolfi PP; Jonjić S; Olive D; Dalod M; Vivier E; Nunès JA
    EMBO J; 2014 Sep; 33(17):1928-40. PubMed ID: 24963146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the CD200 receptor family in mice and humans and their interactions with CD200.
    Wright GJ; Cherwinski H; Foster-Cuevas M; Brooke G; Puklavec MJ; Bigler M; Song Y; Jenmalm M; Gorman D; McClanahan T; Liu MR; Brown MH; Sedgwick JD; Phillips JH; Barclay AN
    J Immunol; 2003 Sep; 171(6):3034-46. PubMed ID: 12960329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylation-associated DOK1 and DOK2 down-regulation: Potential biomarkers for predicting adverse prognosis in acute myeloid leukemia.
    He PF; Xu ZJ; Zhou JD; Li XX; Zhang W; Wu DH; Zhang ZH; Lian XY; Yao XY; Deng ZQ; Lin J; Qian J
    J Cell Physiol; 2018 Sep; 233(9):6604-6614. PubMed ID: 29150948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylation of Dok1 by Abl family kinases inhibits CrkI transforming activity.
    Ng KY; Yin T; Machida K; Wu YI; Mayer BJ
    Oncogene; 2015 May; 34(20):2650-9. PubMed ID: 25043303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant CD200 protein does not bind activating proteins closely related to CD200 receptor.
    Hatherley D; Cherwinski HM; Moshref M; Barclay AN
    J Immunol; 2005 Aug; 175(4):2469-74. PubMed ID: 16081818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization and functionality of the CD200-CD200R system during mesenchymal stromal cell interactions with T-lymphocytes.
    Najar M; Raicevic G; Jebbawi F; De Bruyn C; Meuleman N; Bron D; Toungouz M; Lagneaux L
    Immunol Lett; 2012 Aug; 146(1-2):50-6. PubMed ID: 22575528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Shb scaffold binds the Nck adaptor protein, p120 RasGAP, and Chimaerins and thereby facilitates heterotypic cell segregation by the receptor EphB2.
    Wagner MJ; Hsiung MS; Gish GD; Bagshaw RD; Doodnauth SA; Soliman MA; Jørgensen C; Tucholska M; Rottapel R
    J Biol Chem; 2020 Mar; 295(12):3932-3944. PubMed ID: 32060095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.